| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | tryptophan | 0.6724 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7171 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7226 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7234 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7278 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7348 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7524 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7545 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7728 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7911 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7914 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.7962 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8045 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8058 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8079 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8182 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8245 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8245 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8307 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8345 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8415 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8471 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8499 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8536 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8541 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8594 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8604 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8630 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8666 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8691 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8822 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8845 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8851 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8871 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8878 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8931 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8933 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.8950 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9004 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9015 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9103 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9109 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9117 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9119 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9252 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9269 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9276 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9307 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9331 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9342 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9384 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9393 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9418 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9418 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9421 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9429 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9443 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9495 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9497 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9514 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9530 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9565 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9570 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9582 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9584 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9626 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9627 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9629 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9650 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9654 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9697 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9706 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9708 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9726 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9729 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9746 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9758 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9777 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9784 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9784 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9787 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9804 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9810 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9814 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9816 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9826 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9835 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9887 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9890 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9911 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9914 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9947 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 0.9967 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0000 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0040 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0048 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0053 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0088 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0138 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0145 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0160 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0176 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0177 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0207 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0208 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0235 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0254 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0258 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0261 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0307 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0337 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0361 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0398 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0408 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0411 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0457 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0467 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0469 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0524 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0528 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0568 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0576 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0578 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0590 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0602 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0605 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0625 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0634 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0652 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0686 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0719 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0745 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0777 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0797 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0798 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0829 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0844 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0855 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0943 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0947 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.0997 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1016 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1023 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1026 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1077 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1151 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1181 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1190 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1203 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1254 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1295 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1342 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1360 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1399 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1553 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1555 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1566 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1590 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1624 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1626 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1758 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1781 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1813 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1823 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1841 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.1944 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2042 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2084 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2102 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2200 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2207 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2235 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2248 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2294 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2340 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2405 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2408 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2411 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2430 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2470 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2550 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2562 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2838 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.2851 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.3093 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.3099 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | tryptophan | 1.3171 | scaled units | Low-Dose | -0.5HR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|